These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 396979)

  • 21. Metabolic activation of 2-acetylaminofluorene.
    Thorgeirsson SS; Wirth PJ; Staiano N; Smith CL
    Adv Exp Med Biol; 1981; 136 Pt B():897-919. PubMed ID: 7046390
    [No Abstract]   [Full Text] [Related]  

  • 22. Main pathway for mutagenic activation of 2-acetylaminofluorene by guinea pig liver homogenates.
    Kaneda S; Seno T; Takeishi K
    Biochem Biophys Res Commun; 1979 Oct; 90(3):750-6. PubMed ID: 116658
    [No Abstract]   [Full Text] [Related]  

  • 23. Mutagenicity and DNA damage induced by arylamines in the Salmonella/hepatocyte system.
    Staiano N; Erickson LC; Smith CL; Marsden E; Thorgeirsson SS
    Carcinogenesis; 1983; 4(2):161-7. PubMed ID: 6337737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of non-oxidative enzymes in mutagenic activation of urine from rats, given benzidine and some other aromatic amines.
    Bos RP; Brouns RM; van Doorn R; Theuws JL; Henderson PT
    Toxicology; 1981; 21(3):223-33. PubMed ID: 7027539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of the mutagenicity of 2-acetylaminofluorene by flavonoids and the structural requirements.
    Ogawa S; Hirayama T; Sumida Y; Tokuda M; Hirai K; Fukui S
    Mutat Res; 1987 Feb; 190(2):107-12. PubMed ID: 3547114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comutagenic effect of norharman and harman with 2-acetylaminofluorene derivatives.
    Umezawa K; Shirai A; Matsushima T; Sugimura T
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):928-30. PubMed ID: 345280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the guinea pig liver microsomal 2-fluorenylamine and N-2-fluorenylacetamide N-hydroxylase.
    Razzouk C; Mercier M; Roberfroid M
    Cancer Lett; 1980 Apr; 9(2):123-31. PubMed ID: 7379042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
    Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
    Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between DNA strand breaks and specific DNA adducts in murine hepatocytes following in vivo and in vitro exposure to N-hydroxy-2-acetylaminofluorene and N-acetoxy-2-acetylaminofluorene.
    Vu VT; Møller ME; Grantham PH; Wirth PJ; Thorgeirsson SS
    Carcinogenesis; 1985 Jan; 6(1):45-52. PubMed ID: 4038475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction, activation, and inhibition of hamster and rat liver microsomal arylamide and arylamine N-hydroxylase.
    Razzouk C; Mercier M; Roberfroid M
    Cancer Res; 1980 Oct; 40(10):3540-6. PubMed ID: 7438040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the inhibition of deacetylase in primary cultures of rat and human hepatocytes effecting metabolism and DNA-binding of 2-acetylaminofluorene.
    Monteith DK; Strom SC
    Cell Biol Toxicol; 1990 Jul; 6(3):269-84. PubMed ID: 2253053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
    Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
    Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
    [No Abstract]   [Full Text] [Related]  

  • 33. Mutagenicity of structurally related aromatic amines in the Salmonella/mammalian microsome test with various S-9 fractions.
    Shahin MM; Chopy C; Mayet MJ; Lequesne N
    Food Chem Toxicol; 1983 Oct; 21(5):615-9. PubMed ID: 6360828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective induction of microsomal 2-acetylaminofluorene N-hydroxylation by dietary 2-acetylaminofluorene in rats.
    Sato M; Yoshida T; Suzuki Y; Degawa M; Hashimoto Y
    Carcinogenesis; 1981; 2(7):571-4. PubMed ID: 7023732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevation of hepatic microsomal epoxide hydrolase activity by 2-acetylaminofluorene: strain and species differences.
    Graichen ME; Dent JG
    Carcinogenesis; 1984 Jan; 5(1):23-8. PubMed ID: 6690083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of 6-aminochrysene to genotoxic products by different forms of rat liver cytochrome P450 in an O-acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009).
    Yamazaki H; Shimada T
    Biochem Pharmacol; 1992 Sep; 44(5):913-20. PubMed ID: 1530660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.
    Jacobs MM; Matney TS; Griffin AC
    Cancer Lett; 1977 May; 2(6):319-22. PubMed ID: 324608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of genotoxic and cytotoxic effects of aromatic amines in monolayers of rat hepatocytes.
    Holme JA; Søderlund EJ
    Cell Biol Toxicol; 1984 Oct; 1(1):95-110. PubMed ID: 6400924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inter-individual variation in the mutagenic activation of 2-acetylaminofluorene by human liver in relation to animal metabolic models.
    Smith AJ; Chipman JK
    Mutagenesis; 1988 Jul; 3(4):323-8. PubMed ID: 3062320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Species differences in the cytotoxic and genotoxic effects of 2-acetylaminofluorene and its primary metabolites 2-aminofluorene and N-OH-2-acetylaminofluorene.
    Holme JA; Søderlund EJ
    Carcinogenesis; 1985 Mar; 6(3):421-5. PubMed ID: 3978756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.